New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season
1 year ago
166
U.S. officials connected Monday approved the archetypal long-acting cause to support babies and toddlers against a respiratory microorganism that sends tens of thousands of American children to the infirmary each year.